Condition:   Psoriatic Arthritis
Interventions:   Drug: Tofacitinib (CP-690,550);   Drug: Tofacitinib (CP-690,550);   Drug: Placebo;   Drug: Placebo
Sponsor:   Pfizer
Not yet recruiting - verified August 2011